Ignite Creation Date:
2024-05-06 @ 1:48 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04124965
Status:
COMPLETED
Last Update Posted:
2023-09-05
First Post:
2019-10-11
Brief Title:
A Study to Investigate the Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-11
First Submit QC Date:
October 11 2019
Study First Post Date:
2019-10-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-31
Disp First Submit QC Date:
September 1 2022
Disp First Post Date:
2022-09-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-08-22
Last Update Post Date:
2023-09-05
Last Update Post Date Type:
ACTUAL